Rise Advisors, LLC Repligen Corp Transaction History

Rise Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$119.79 - $167.35 $5,749 - $8,032	-48 Reduced 49.48%	49 $7,000
Q2 2024 Jul 09, 2024	SELL	$120.0 - $182.95 $240 - $365	-2 Reduced 2.02%	97 $12,000
Q1 2024 Apr 09, 2024	SELL	$170.78 - $208.42 $4,098 - $5,002	-24 Reduced 19.51%	99 $18,000
Q3 2023 Oct 10, 2023	SELL	$138.78 - $176.51 $3,747 - $4,765	-27 Reduced 18.0%	123 $19,000
Q2 2023 Jul 10, 2023	SELL	$138.42 - $180.31 $5,813 - $7,573	-42 Reduced 21.88%	150 $21,000
Q3 2022 Oct 11, 2022	SELL	$160.42 - $256.21 $481 - $768	-3 Reduced 1.54%	192 $36,000
Q4 2021 Feb 24, 2022	BUY	$247.59 - $304.47 $48,280 - $59,371	195 New	195 $51.6 Million

479

54.9M

297K

343K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.15B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Rise Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Rise Advisors, LLC with notifications on news.